|
StatsDirect ltd
statsdirect software Statsdirect Software, supplied by StatsDirect ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/mann%E2%80%93whitney+tests+in+graphpad+prism/pmc05668975-81-6-11?v=StatsDirect+ltd Average 90 stars, based on 1 article reviews
statsdirect software - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
RStudio
statistics mann whitney non-parametric test Statistics Mann Whitney Non Parametric Test, supplied by RStudio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/mann%E2%80%93whitney+tests+in+graphpad+prism/ppr0375076-280-0-9?v=RStudio Average 90 stars, based on 1 article reviews
statistics mann whitney non-parametric test - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
OriGene
2017 n a agxt human tagged orf ![]() 2017 N A Agxt Human Tagged Orf, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/mann%E2%80%93whitney+tests+in+graphpad+prism/pm34320345-277-135-142?v=OriGene Average 90 stars, based on 1 article reviews
2017 n a agxt human tagged orf - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
STATA Corporation
inc software ![]() Inc Software, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/mann%E2%80%93whitney+tests+in+graphpad+prism/10__7554_slash_elife__87394-270-134-137?v=STATA+Corporation Average 99 stars, based on 1 article reviews
inc software - by Bioz Stars,
2026-08
99/100 stars
|
Buy from Supplier |
|
RStudio
kruskal-wallis rank sum test ![]() Kruskal Wallis Rank Sum Test, supplied by RStudio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/mann%E2%80%93whitney+tests+in+graphpad+prism/pm39547411-235-13-30?v=RStudio Average 90 stars, based on 1 article reviews
kruskal-wallis rank sum test - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
Addgene inc
il21 ![]() Il21, supplied by Addgene inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/mann%E2%80%93whitney+tests+in+graphpad+prism/pm39536753-222-19-31?v=Addgene+inc Average 92 stars, based on 1 article reviews
il21 - by Bioz Stars,
2026-08
92/100 stars
|
Buy from Supplier |
|
STATCON GmbH
mann–whitney u-test ![]() Mann–Whitney U Test, supplied by STATCON GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/mann%E2%80%93whitney+tests+in+graphpad+prism/pmc09264852-146-27-48?v=STATCON+GmbH Average 90 stars, based on 1 article reviews
mann–whitney u-test - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
RStudio
r studio software ![]() R Studio Software, supplied by RStudio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/mann%E2%80%93whitney+tests+in+graphpad+prism/pmc04714604-111-13-34?v=RStudio Average 90 stars, based on 1 article reviews
r studio software - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
MedCalc Software Ltd
fisher’s exact test ![]() Fisher’s Exact Test, supplied by MedCalc Software Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/mann%E2%80%93whitney+tests+in+graphpad+prism/pmc07882535-84-10-23?v=MedCalc+Software+Ltd Average 90 stars, based on 1 article reviews
fisher’s exact test - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
Dotmatics Limited
mann whitney test ![]() Mann Whitney Test, supplied by Dotmatics Limited, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/mann%E2%80%93whitney+tests+in+graphpad+prism/10__2147_slash_lctt__s455034-75-1-10?v=Dotmatics+Limited Average 86 stars, based on 1 article reviews
mann whitney test - by Bioz Stars,
2026-08
86/100 stars
|
Buy from Supplier |
|
Addgene inc
algorithms synapsemech ![]() Algorithms Synapsemech, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/mann%E2%80%93whitney+tests+in+graphpad+prism/pm36113483-191-97-92?v=Addgene+inc Average 93 stars, based on 1 article reviews
algorithms synapsemech - by Bioz Stars,
2026-08
93/100 stars
|
Buy from Supplier |
|
Xybion Inc
mann whitney two ![]() Mann Whitney Two, supplied by Xybion Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/mann%E2%80%93whitney+tests+in+graphpad+prism/pm14563402-96-22-26?v=Xybion+Inc Average 86 stars, based on 1 article reviews
mann whitney two - by Bioz Stars,
2026-08
86/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Cell reports
Article Title: Dysregulated oxalate metabolism is a driver and therapeutic target in atherosclerosis.
doi: 10.1016/j.celrep.2021.109420
Figure Lengend Snippet: Figure 1. Dysregulated glycine and oxalate metabolism in patients and mice with atherosclerosis (A) Schematic representation of glycine metabolic pathways. (B–E) Targeted metabolomics assessing the ratios of glycine to (B) serine, (C) threonine, (D) alanine, and (E) oxalate in serum from age- and sex- matched patients with or without sCAD (n = 24). (F) En face analysis of atherosclerotic lesions in male Apoe/ mice fed a standard diet (SD) or Western diet (WD) for 12 weeks (n = 5). (G–J) Targeted metabolomics assessing the ratios of glycine to (G) serine, (H) threonine, (I) alanine, and (J) oxalate in plasma from male Apoe/ mice fed a SD or WD for 12 weeks (n = 5). (K) Western blot analysis of AGXT protein abun- dance in livers from Apoe/ mice fed a SD or WD for 12 weeks (n = 5). Mann-Whitney U test for (B)-(E), (G), (H), and (K). Unpaired t test for (F), (I), and (J). Data are pre- sented as mean ± SEM. All points and p values are shown.
Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Primer sequences for Agxt genotyping:, forward: 50-ACACCTCCACTGTCCTG TCC-30 Integrated DNA Technologies N/A Primer sequences for Agxt genotyping:, reverse: 50-GGTCAGATCTGCCTGCTA CC-30 Integrated DNA Technologies N/A Primer for Sanger sequencing:, 50-GCAGAGCTAGCTGGGAAATG-30 Integrated DNA Technologies N/A Primer sequences for Apoe genotyping:, forward: 50-GCCTAGCCGAGGGAGAG CCG-30 Integrated DNA Technologies N/A Primer sequences for Apoe genotyping:, reverse 1: 50-TGTGACTTGGGAGCTC TGCAGC-30 Integrated DNA Technologies N/A Primer sequences for Apoe genotyping:, reverse 2: 50-GCCGCCCCGACTGC ATCT-30 Integrated DNA Technologies N/A Primer sequences for qPCR, see Table S2 Integrated DNA Technologies N/A Recombinant DNA pAdDeltaF6 Jiandie Lin’s lab, University of Michigan; Guo et al., 2017 N/A pAAV2/8 Jiandie Lin’s lab, University of Michigan; Guo et al., 2017 N/A pAAV-TBG-GFP Jiandie Lin’s lab, University of Michigan; Guo et al., 2017 N/A pAAV-TBG-MCS Jiandie Lin’s lab, University of Michigan; Guo et al.,
Techniques: Western Blot, Clinical Proteomics, MANN-WHITNEY
Journal: Cell reports
Article Title: Dysregulated oxalate metabolism is a driver and therapeutic target in atherosclerosis.
doi: 10.1016/j.celrep.2021.109420
Figure Lengend Snippet: Figure 2. AGXT deficiency exacerbates atherosclerosis in male Apoe/ mice (A) Western blot analysis confirming the loss of AGXT in livers from male Agxt//Apoe/ mice (n = 6). (B) Glycine/oxalate ratio in plasma from male Agxt//Apoe/ mice and their Agxt+/+/Apoe/
Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Primer sequences for Agxt genotyping:, forward: 50-ACACCTCCACTGTCCTG TCC-30 Integrated DNA Technologies N/A Primer sequences for Agxt genotyping:, reverse: 50-GGTCAGATCTGCCTGCTA CC-30 Integrated DNA Technologies N/A Primer for Sanger sequencing:, 50-GCAGAGCTAGCTGGGAAATG-30 Integrated DNA Technologies N/A Primer sequences for Apoe genotyping:, forward: 50-GCCTAGCCGAGGGAGAG CCG-30 Integrated DNA Technologies N/A Primer sequences for Apoe genotyping:, reverse 1: 50-TGTGACTTGGGAGCTC TGCAGC-30 Integrated DNA Technologies N/A Primer sequences for Apoe genotyping:, reverse 2: 50-GCCGCCCCGACTGC ATCT-30 Integrated DNA Technologies N/A Primer sequences for qPCR, see Table S2 Integrated DNA Technologies N/A Recombinant DNA pAdDeltaF6 Jiandie Lin’s lab, University of Michigan; Guo et al., 2017 N/A pAAV2/8 Jiandie Lin’s lab, University of Michigan; Guo et al., 2017 N/A pAAV-TBG-GFP Jiandie Lin’s lab, University of Michigan; Guo et al., 2017 N/A pAAV-TBG-MCS Jiandie Lin’s lab, University of Michigan; Guo et al.,
Techniques: Western Blot, Clinical Proteomics
Journal: Cell reports
Article Title: Dysregulated oxalate metabolism is a driver and therapeutic target in atherosclerosis.
doi: 10.1016/j.celrep.2021.109420
Figure Lengend Snippet: Figure 3. Oxalate homeostasis is main- tained and atherosclerosis is unaltered in fe- male Agxt//Apoe/ mice (A) Western blot analysis confirming the loss of AGXT in livers from female Agxt//Apoe/ mice (n = 6). (B) GlGlycine/oxalate ratio in plasma from female Agxt//Apoe/ and Agxt+/+/Apoe/ mice (n = 10). (C–G) Female Agxt//Apoe/ and Agxt+/+/ Apoe/ mice were fed a WD for 12 weeks (n = 10): (C) plasma TC, (D) atherosclerosis in the aortic tree, (E) H&E staining, (F) ORO staining, and (G) Mac-2 immunohistochemistry of aortic sinus. Scale bars, 200 mm. Unpaired t test for (B), (D), (E), and (G). Mann- Whitney U test for (C) and (F). Data are presented as mean ± SEM. All points and p values are shown.
Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Primer sequences for Agxt genotyping:, forward: 50-ACACCTCCACTGTCCTG TCC-30 Integrated DNA Technologies N/A Primer sequences for Agxt genotyping:, reverse: 50-GGTCAGATCTGCCTGCTA CC-30 Integrated DNA Technologies N/A Primer for Sanger sequencing:, 50-GCAGAGCTAGCTGGGAAATG-30 Integrated DNA Technologies N/A Primer sequences for Apoe genotyping:, forward: 50-GCCTAGCCGAGGGAGAG CCG-30 Integrated DNA Technologies N/A Primer sequences for Apoe genotyping:, reverse 1: 50-TGTGACTTGGGAGCTC TGCAGC-30 Integrated DNA Technologies N/A Primer sequences for Apoe genotyping:, reverse 2: 50-GCCGCCCCGACTGC ATCT-30 Integrated DNA Technologies N/A Primer sequences for qPCR, see Table S2 Integrated DNA Technologies N/A Recombinant DNA pAdDeltaF6 Jiandie Lin’s lab, University of Michigan; Guo et al., 2017 N/A pAAV2/8 Jiandie Lin’s lab, University of Michigan; Guo et al., 2017 N/A pAAV-TBG-GFP Jiandie Lin’s lab, University of Michigan; Guo et al., 2017 N/A pAAV-TBG-MCS Jiandie Lin’s lab, University of Michigan; Guo et al.,
Techniques: Western Blot, Clinical Proteomics, Staining, Immunohistochemistry, MANN-WHITNEY
Journal: Cell reports
Article Title: Dysregulated oxalate metabolism is a driver and therapeutic target in atherosclerosis.
doi: 10.1016/j.celrep.2021.109420
Figure Lengend Snippet: Figure 4. Dysregulated oxalate metabolism induces a pro-inflammatory response and CCL5 release (A–C) RNA sequencing of livers collected from male Agxt//Apoe/ and Agxt+/+/Apoe/ mice fed a WD for 12 weeks (n = 5): (A) volcano plot of DEGs (padj < 0.05, log2 fold change > 1) in male Agxt//Apoe/ versus Agxt+/+/Apoe/ mice (blue indicates downregulated; red indicates upregulated). (B) Kyoto Encyclopedia of Genes and Genomes (KEGG)-based pathway analysis. The significance of the enrichment was determined by a right-tailed Fisher’s exact test followed by a Benjamini-Hochberg multiple testing adjustment. (C) Heatmap-based representation of 50 DEGs linking inflammation, fibrogenesis, and the metabolism of lipids and sterols/steroids with atherosclerosis.
Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Primer sequences for Agxt genotyping:, forward: 50-ACACCTCCACTGTCCTG TCC-30 Integrated DNA Technologies N/A Primer sequences for Agxt genotyping:, reverse: 50-GGTCAGATCTGCCTGCTA CC-30 Integrated DNA Technologies N/A Primer for Sanger sequencing:, 50-GCAGAGCTAGCTGGGAAATG-30 Integrated DNA Technologies N/A Primer sequences for Apoe genotyping:, forward: 50-GCCTAGCCGAGGGAGAG CCG-30 Integrated DNA Technologies N/A Primer sequences for Apoe genotyping:, reverse 1: 50-TGTGACTTGGGAGCTC TGCAGC-30 Integrated DNA Technologies N/A Primer sequences for Apoe genotyping:, reverse 2: 50-GCCGCCCCGACTGC ATCT-30 Integrated DNA Technologies N/A Primer sequences for qPCR, see Table S2 Integrated DNA Technologies N/A Recombinant DNA pAdDeltaF6 Jiandie Lin’s lab, University of Michigan; Guo et al., 2017 N/A pAAV2/8 Jiandie Lin’s lab, University of Michigan; Guo et al., 2017 N/A pAAV-TBG-GFP Jiandie Lin’s lab, University of Michigan; Guo et al., 2017 N/A pAAV-TBG-MCS Jiandie Lin’s lab, University of Michigan; Guo et al.,
Techniques: RNA Sequencing
Journal: Cell reports
Article Title: Dysregulated oxalate metabolism is a driver and therapeutic target in atherosclerosis.
doi: 10.1016/j.celrep.2021.109420
Figure Lengend Snippet: Figure 5. Oxalate overload induces mito- chondrial dysfunction and overproduction of superoxide, leading to CCL5 release in macrophages (A) qPCR analyses of genes regulating redox ho- meostasis in livers from male Agxt//Apoe/
Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Primer sequences for Agxt genotyping:, forward: 50-ACACCTCCACTGTCCTG TCC-30 Integrated DNA Technologies N/A Primer sequences for Agxt genotyping:, reverse: 50-GGTCAGATCTGCCTGCTA CC-30 Integrated DNA Technologies N/A Primer for Sanger sequencing:, 50-GCAGAGCTAGCTGGGAAATG-30 Integrated DNA Technologies N/A Primer sequences for Apoe genotyping:, forward: 50-GCCTAGCCGAGGGAGAG CCG-30 Integrated DNA Technologies N/A Primer sequences for Apoe genotyping:, reverse 1: 50-TGTGACTTGGGAGCTC TGCAGC-30 Integrated DNA Technologies N/A Primer sequences for Apoe genotyping:, reverse 2: 50-GCCGCCCCGACTGC ATCT-30 Integrated DNA Technologies N/A Primer sequences for qPCR, see Table S2 Integrated DNA Technologies N/A Recombinant DNA pAdDeltaF6 Jiandie Lin’s lab, University of Michigan; Guo et al., 2017 N/A pAAV2/8 Jiandie Lin’s lab, University of Michigan; Guo et al., 2017 N/A pAAV-TBG-GFP Jiandie Lin’s lab, University of Michigan; Guo et al., 2017 N/A pAAV-TBG-MCS Jiandie Lin’s lab, University of Michigan; Guo et al.,
Techniques:
Journal: Cell reports
Article Title: Dysregulated oxalate metabolism is a driver and therapeutic target in atherosclerosis.
doi: 10.1016/j.celrep.2021.109420
Figure Lengend Snippet: Figure 6. AAV-mediated overexpression of AGXT reduces oxidative stress and inflammation AAV-AGXT or AAV-GFP was injected into male Apoe/ mice and the mice were fed a WD for 12 weeks (n = 8). (A) Western blot analysis confirming the over- expression of AGXT in livers from mice treated with AAV-AGXT. (B) Plasma glycine/oxalate ratio. (C and D) qPCR analyses of genes regulating (C) redox homeostasis and (D) inflammatory re- sponses. Gene expression levels were normalized to 18S. (E and F) Plasma concentrations of (E) CCL2 and (F) CCL5. (G) DHE fluorescence and Mac-2 immunofluores- cence in the aortic sinuses. Scale bars, 50 mm. Unpaired t test for (B), (E), and (G), and Mann- Whitney U test for (F). Statistical differences in gene expression in (C) and (D) were tested using unpaired t test or Mann-Whitney U test, depending on normality tests. *P < 0.05, **P <0.01, ***P <0.001 versus mice injected with AAV-GFP. Data are presented as mean ± SEM. All points and p values are shown.
Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Primer sequences for Agxt genotyping:, forward: 50-ACACCTCCACTGTCCTG TCC-30 Integrated DNA Technologies N/A Primer sequences for Agxt genotyping:, reverse: 50-GGTCAGATCTGCCTGCTA CC-30 Integrated DNA Technologies N/A Primer for Sanger sequencing:, 50-GCAGAGCTAGCTGGGAAATG-30 Integrated DNA Technologies N/A Primer sequences for Apoe genotyping:, forward: 50-GCCTAGCCGAGGGAGAG CCG-30 Integrated DNA Technologies N/A Primer sequences for Apoe genotyping:, reverse 1: 50-TGTGACTTGGGAGCTC TGCAGC-30 Integrated DNA Technologies N/A Primer sequences for Apoe genotyping:, reverse 2: 50-GCCGCCCCGACTGC ATCT-30 Integrated DNA Technologies N/A Primer sequences for qPCR, see Table S2 Integrated DNA Technologies N/A Recombinant DNA pAdDeltaF6 Jiandie Lin’s lab, University of Michigan; Guo et al., 2017 N/A pAAV2/8 Jiandie Lin’s lab, University of Michigan; Guo et al., 2017 N/A pAAV-TBG-GFP Jiandie Lin’s lab, University of Michigan; Guo et al., 2017 N/A pAAV-TBG-MCS Jiandie Lin’s lab, University of Michigan; Guo et al.,
Techniques: Over Expression, Injection, Western Blot, Clinical Proteomics, Gene Expression, MANN-WHITNEY
Journal: Cell reports
Article Title: Dysregulated oxalate metabolism is a driver and therapeutic target in atherosclerosis.
doi: 10.1016/j.celrep.2021.109420
Figure Lengend Snippet: Figure 7. AAV-mediated overexpression of AGXT reduces atherosclerosis independent of circulating cholesterol AAV-AGXT or AAV-GFP was injected into male Apoe/ mice and the mice were fed a WD for 12 weeks (n = 8). (A) Plasma TC. (B) Atherosclerosis in the aortic tree. (C–E) H&E staining (D), ORO staining (D), and Mac- 2 immunohistochemistry (E) of aortic sinus. Scale bars, 200 mm. (F) Proposed model of dysregulated oxalate metabolism as a driver and therapeutic target in atherosclerosis. Unpaired t test for (A)–(E). Data are presented as mean ± SEM. All points and p values are shown.
Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Primer sequences for Agxt genotyping:, forward: 50-ACACCTCCACTGTCCTG TCC-30 Integrated DNA Technologies N/A Primer sequences for Agxt genotyping:, reverse: 50-GGTCAGATCTGCCTGCTA CC-30 Integrated DNA Technologies N/A Primer for Sanger sequencing:, 50-GCAGAGCTAGCTGGGAAATG-30 Integrated DNA Technologies N/A Primer sequences for Apoe genotyping:, forward: 50-GCCTAGCCGAGGGAGAG CCG-30 Integrated DNA Technologies N/A Primer sequences for Apoe genotyping:, reverse 1: 50-TGTGACTTGGGAGCTC TGCAGC-30 Integrated DNA Technologies N/A Primer sequences for Apoe genotyping:, reverse 2: 50-GCCGCCCCGACTGC ATCT-30 Integrated DNA Technologies N/A Primer sequences for qPCR, see Table S2 Integrated DNA Technologies N/A Recombinant DNA pAdDeltaF6 Jiandie Lin’s lab, University of Michigan; Guo et al., 2017 N/A pAAV2/8 Jiandie Lin’s lab, University of Michigan; Guo et al., 2017 N/A pAAV-TBG-GFP Jiandie Lin’s lab, University of Michigan; Guo et al., 2017 N/A pAAV-TBG-MCS Jiandie Lin’s lab, University of Michigan; Guo et al.,
Techniques: Over Expression, Injection, Clinical Proteomics, Staining, Immunohistochemistry
Journal: Cell reports. Medicine
Article Title: IL-21/IL-21R signaling renders acute myeloid leukemia stem cells more susceptible to cytarabine treatment and CAR T cell therapy.
doi: 10.1016/j.xcrm.2024.101826
Figure Lengend Snippet: Figure 1. IL-21/IL-21R signaling reduces murine L-GMPs in vivo (A) Il21R mRNA expression (qRT-PCR) in FACS-sorted L-GMPs from the BM of BL/6 AML mice 35 days after leukemia transplantation (n = 10 mice). Red bar indicates the mean. Each dot represents the mean of two technical replicates. (B) IL-21 levels in BM samples from AML mice (n = 11 mice) and naive controls (n = 5 mice). Each dot represents the mean of two technical replicates. Data are shown as mean ± SEM. Statistics: Student’s t test. (C) Fold change colony-forming units from FACS-sorted L-GMPs cultured in methylcellulose for 7 days in the presence or absence of 300 pg/mL rm-IL-21 (n = 6 mice/group). Each dot represents the mean of two technical replicates. Pooled data from two independent experiments are shown and displayed as mean ± SD. Statistics: Student’s t test. (D) Experimental setup: 5 3 104 MLL-AF9-GFP-transduced LSKs from the BM of BL/6 donors were injected intravenously into non-irradiated BL/6 and Il21/
Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Experimental models: Organisms/strains Mouse: C57BL/6J Charles River MGI: 3028467 Il21R / (B6.129-Il21rtm1Kopf/J) MGI: 5435248
Techniques: In Vivo, Expressing, Quantitative RT-PCR, Transplantation Assay, Cell Culture, Injection, Irradiation
Journal: Cell reports. Medicine
Article Title: IL-21/IL-21R signaling renders acute myeloid leukemia stem cells more susceptible to cytarabine treatment and CAR T cell therapy.
doi: 10.1016/j.xcrm.2024.101826
Figure Lengend Snippet: Figure 3. CD4+ T cell-derived IL-21 reduces murine LSCs in vivo (A and B) MLL-AF9 AML was induced in Il21mcherry reporter mice. Frequencies of mcherry-Il21+ CD4+ T cells (A) and CD4+ mcherry-Il21+ cells (B) were determined by flow cytometry 16 and 33 days after leukemia transplantation, in BM of AML and naive Il21mcherry mice (n = 4 mice/group). (C) Experimental setup: 5 3 106 CD4+ T cells were FACS-sorted from the spleens of CD45.1 mice and injected intravenously into two out of four experimental groups (non-irradiated BL/6 and Il21/ recipients) one day prior to leukemia transplantation. One day after, 5 3 104 MLL-AF9-GFP-transduced LSKs from the BM of BL/6 donors were injected intravenously into all four experimental groups (BL/6 AML, Il21/ AML, BL/6 AML + CD4+, and Il21/ AML + CD4+, respectively). Mice were sacrificed 35 days after leukemia transplantation and BM and spleen were analyzed (n = 4 mice/group). (D–G) Spleen size (D), number of MLL-AF9-GFP+ leukemic cells in BM (E) and in peripheral blood (F), and number of L-GMPs (G) in the BM of BL/6 AML, Il21/
Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Experimental models: Organisms/strains Mouse: C57BL/6J Charles River MGI: 3028467 Il21R / (B6.129-Il21rtm1Kopf/J) MGI: 5435248
Techniques: Derivative Assay, In Vivo, Cytometry, Transplantation Assay, Injection, Irradiation
Journal: Cell reports. Medicine
Article Title: IL-21/IL-21R signaling renders acute myeloid leukemia stem cells more susceptible to cytarabine treatment and CAR T cell therapy.
doi: 10.1016/j.xcrm.2024.101826
Figure Lengend Snippet: Figure 4. IL-21 is an independent positive prognostic marker for OS in AML (A) IL-21 levels in serum samples from newly diagnosed patients with AML (n = 193) and age-matched healthy controls (n = 10). Each dot represents the mean of two technical replicates. Red bars indicate the mean. Statistics: Mann-Whitney test. (B) Kaplan-Meier survival curves of the AML patients’ cohort (n = 193) divided into two groups at the IL-21 serum levels (sIL-21) threshold of 29 pg/mL. Statistics: log rank test. (C) Correlation of patients’ age with sIL-21 levels. Statistics: Pearson r test. (D) sIL-21 of patients in the different risk groups. Red bars indicate the mean. Statistics: one-way ANOVA. (E) Multivariate analysis for sIL-21 adjusted for BM infiltration, leukocyte counts, percentage of peripheral blood blasts, age, and risk group. Statistics: multiple Cox regression. (F and G) Two publicly available microarray datasets were analyzed for IL21 mRNA expression levels and their association with prognosis. Statistics: log rank test. (F) Valk dataset, accession number GSE6891, sIL-21 threshold 6.91 RPKM. (G) Metzeler dataset, accession number GSE12417, sIL-21 threshold 7.54 RPKM. (H–K) Enrichment plots depicting significantly enriched gene sets in patients with high levels of IL-21. HSC differentiation and lineage-specific markers (H), positive regulation of stem cell proliferation (I), Fridman-senescence-DN (J), Stemness-UP (K). Gene sets were derived from the Metzeler dataset, accession number GSE12417. Normalized enrichment score (NES) and p value are indicated for each plot. *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001. Abbreviations: OS, overall survival; yr, years; fav., favorable; int., intermediate; adv., adverse; HR, hazard ratio; CI, confidence interval; PB, peripheral blood; RPKM, reads per kilobase per million mapped reads; NES, normalized enrichment score. See also Figure S5.
Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Experimental models: Organisms/strains Mouse: C57BL/6J Charles River MGI: 3028467 Il21R / (B6.129-Il21rtm1Kopf/J) MGI: 5435248
Techniques: Marker, MANN-WHITNEY, Microarray, Expressing, Derivative Assay
Journal: Cell reports. Medicine
Article Title: IL-21/IL-21R signaling renders acute myeloid leukemia stem cells more susceptible to cytarabine treatment and CAR T cell therapy.
doi: 10.1016/j.xcrm.2024.101826
Figure Lengend Snippet: Figure 5. IL-21 is produced by CD4+ T cells and reduces cell growth and colony-forming capacity of AML stem and progenitor cells in vitro (A) IL21 mRNA expression (qRT-PCR) in FACS-sorted CD4+ T cells (n = 32), CD8+ T cells (n = 27), and CD45dimSSClolinCD34+ LSPCs (n = 13) from newly diagnosed patients with AML. Red bars indicate the mean. Statistics: one-way ANOVA.
Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Experimental models: Organisms/strains Mouse: C57BL/6J Charles River MGI: 3028467 Il21R / (B6.129-Il21rtm1Kopf/J) MGI: 5435248
Techniques: Produced, In Vitro, Expressing, Quantitative RT-PCR
Journal: Cell reports. Medicine
Article Title: IL-21/IL-21R signaling renders acute myeloid leukemia stem cells more susceptible to cytarabine treatment and CAR T cell therapy.
doi: 10.1016/j.xcrm.2024.101826
Figure Lengend Snippet: Figure 6. IL-21/IL-21R signaling promotes the sensitivity of AML LSCs to cytarabine treatment (A) Kaplan-Meier survival curves of patients with AML (n = 110) who received intensive chemotherapy (‘‘7 + 3’’ regimen) as a first-line treatment divided into two groups based on complete remission (CR) achievement. Statistics: log rank test. (B) Kaplan-Meier survival curves of the AML patient cohort that received intensive chemotherapy (n = 110) divided into three groups at the sIL-21 threshold of 29 and 72 pg/mL. Statistics: log rank test. (C) sIL-21 levels in patients who achieved CR (n = 80) versus patients who did not achieve CR (n = 30). Red bars indicate the mean. Statistics: Mann-Whitney test. (D) CR rates in patients with high, intermediate, and low sIL-21 levels. Statistics: chi-square test. (E) LSPCs colonies were enumerated after two weeks of culture in methylcellulose in the presence or absence of 100 pg/mL rh-IL-21, 1 nM cytarabine (AraC), or combination. Each dot represents the mean of three technical replicates. Different colors indicate different patients (n = 11). Data are shown as mean ± SD. Statistics: one-way ANOVA followed by Tukey’s multiple comparisons test. (F and G) LSPCs colonies were enumerated after two weeks of culture in methylcellulose in the presence or absence of 100 pg/mL rh-IL-21, anti-CD70 CAR T cells (1:5 E:T ratio), or combination. Two patients are shown in each graph (each dot represents a technical replicate). Statistics: one-way ANOVA followed by Tukey’s multiple comparisons test. *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001. Abbreviations: ChTh, chemotherapy; OS, overall survival; CR, complete remission; CFU, colony-forming units, AraC, cytosine arabinoside (or cytarabine). See also Figure S7.
Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Experimental models: Organisms/strains Mouse: C57BL/6J Charles River MGI: 3028467 Il21R / (B6.129-Il21rtm1Kopf/J) MGI: 5435248
Techniques: MANN-WHITNEY
Journal: Developmental cell
Article Title: T cell cytoskeletal forces shape synapse topography for targeted lysis via membrane curvature bias of perforin.
doi: 10.1016/j.devcel.2022.08.012
Figure Lengend Snippet: Figure 3. The CTL synapse exhibits negative membrane curvatures at regions cleared of F-actin (A) Timelapse confocal images of live CTL F-actin distribution at the synapse during cognate tumor interaction in the DPA assay. Top: maximum intensity projection. Middle/bottom: SynapseMech analysis of CTL F-actin distribution and membrane curvature within the synapse. Displayed F-actin signal restricted to synapse region and intensity-thresholded. Scale bar, 5 mm. (B) Dynamics of area cleared from F-actin (gray shaded region) and average mean curvature of complete (dark gray) and F-actin-cleared (brown) synapse area for data shown in (A). (C) Time-averaged mean curvature of complete, F-actin-cleared, and F-actin-rich (outside of cleared space) synapse area. Boxplot shows median, IQR, and range for n = 6 cells. p values by matched one-way ANOVA test with prior Kolmogorov-Smirnov test for normality. (D) Surface tension of resting CTLs, tumor cells and tumor cytoplasts. Boxplots show median, IQR and range for n = 24 (CTL), n = 36 (tumor cells), and n = 19 (tumor cytoplasts). p values by Mann-Whitney test. (E) Timelapse confocal images of a live CTL interacting with a cognate tumor cytoplast in the DPA assay. t = 0 s: time of contact. Scale bar, 10 mm. (F) Main: dynamics of average mean synapse curvature of CTL interacting with cognate tumor cell or tumor cytoplast. Data are mean ± SEM (shaded area) for n = 7 (tumor cell) and n = 8 (tumor cytoplast). Inset: time-averaged mean synapse curvature of CTLs interacting with cognate tumor cells or tumor cytoplasts. p value by Mann-Whitney test.
Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Experimental models: Cell lines EL4 mouse lymphoma cells ATCC Cat. #: TIB-39 WM266-4 (Elkin1 KO) human melanoma cells Patkunarajah et al. (2020) N/A Experimental models: Organisms/strains Mouse: C57BL/6 OT-1 Gift from E. Deenick (Garvan Institute of Medical Research) N/A Mouse: C57BL/6 OT-1 x Lifeact-EGFP Galeano Niño et al. (2020) N/A Mouse: C57BL/6 OT-1 x TdTomato Galeano Niño et al. (2020); Muzumdar et al. (2007) N/A Human: primary CTLs transduced with 1G4 TCR Gift from J. Goyette (University of New South Wales) N/A Recombinant DNA Myosin IIA-GFP plasmid
Techniques: Membrane, MANN-WHITNEY